Visceral leishmaniasis in a patient with ulcerative colitis: A case report
Introduction. There is a rise of visceral leishmaniasis in immunocompromised patients due to increased availability of immunomodulatory drugs. In order to point at the occurrence of visceral leishmaniasis in patients with inflammatory bowel disease (IBD), we reported a case of female patient with a...
Main Authors: | Janković Goran, Martinović Lena, Dakić Zorica, Mijač Dragana, Štulić Miloš, Krstić Miodrag |
---|---|
Format: | Article |
Language: | English |
Published: |
Military Health Department, Ministry of Defance, Serbia
2020-01-01
|
Series: | Vojnosanitetski Pregled |
Subjects: | |
Online Access: | http://www.doiserbia.nb.rs/img/doi/0042-8450/2020/0042-84501800076J.pdf |
Similar Items
-
Clinical and endoscopic parameters at presentation that predict the need for long-term immunosuppression in ulcerative colitis
by: Ranjit K. Sreerama, et al.
Published: (2014-01-01) -
IgA, albumin, and eosinopenia as early indicators of cytomegalovirus infection in patients with acute ulcerative colitis
by: Hong Yang, et al.
Published: (2020-09-01) -
Correlation between extraintestinal manifestations and clinical parameters with the histologic activity index in patients with inflammatory bowel diseases
by: Štulić Miloš, et al.
Published: (2013-01-01) -
The etiology of chronic ulcerative colitis
by: Twyble, Ellsworth
Published: (2017) -
Visceral Dissemination of Mucocutaneous Leishmaniasis in a Kidney Transplant Recipient
by: Nídia Marques, et al.
Published: (2021-12-01)